Morningstar

Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial ...

WAYNE, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...
Morningstar

Nu-BAKE from RIBUS Provides a Clean Label Path as Regulations Tighten and Consumer Demand Grows

ST. LOUIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- As new food labeling laws take effect in Texas, and other states consider similar action, there is rising demand on manufacturers to simplify ingredient ...
WKRN-TV

POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled Radioligands

INDIANAPOLIS and SYDNEY, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and ...
WJHL-TV

Kinetic Seas and Sagtec Enter into Major Five-Year Agreement to Launch Private White-Labeled SKILLIKS Platform

SCHAUMBURG, Ill. and KUALA LUMPUR, Malaysia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kinetic Seas Incorporated (OTCQB: KSEZ) and Sagteс Global Limited (NASDAQ: SAGT) today announced the signing of a ...